Pathologists Lancet Kenya Twitter'da: "A Glutamic Acid Decarboxylase Autoantibodies test (GAD antibodies test) is used to help discover whether someone has either type 1 diabetes or Latent Autoimmune Diabetes of Adulthood (LADA).
GAD antibodies and diabetes: What's the connection?
Figure 7 | Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA)
GAD antibodies in neurological disorders — insights and challenges | Nature Reviews Neurology
NAA Services for Anti-glutamic Acid Decarboxylase (GAD) - Creative Biolabs
Medizym® anti-GAD ELISA - DiaPharma
Glutamate Decarboxylase - an overview | ScienceDirect Topics
Detection of anti-glutamic acid decarboxylase 65 (GAD65) antibodies in... | Download Scientific Diagram
Pancreatic autoantibodies: who to test and how to interpret the results - Misra - 2017 - Practical Diabetes - Wiley Online Library
features differentiating between type 1 and type 2 diabetes mellitus - General Practice notebook
Autoantigen Based Vaccines for Type 1 Diabetes - Dequina Nicholas - Discovery Medicine
Levels of anti-GAD at beginning of study and after one year in 11 type... | Download Scientific Diagram
Diabetes Typ 1 oder Typ 2 – Korrekte Diagnose durch Autoantikörper
Should anti-glutamic acid decarboxylase antibody levels be determined in new-onset diabetes? - Endocrine Practice
Diabetes mellitus Typ 1 - DocCheck Flexikon
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions - Popianna Tsiortou, Harry Alexopoulos, Marinos C. Dalakas, 2021
Changing the landscape for type 1 diabetes: the first step to prevention - The Lancet
Neurologic syndromes related to anti-GAD65 | Neurology Neuroimmunology & Neuroinflammation
A Novel Subtype of Type 1 Diabetes Mellitus Characterized by a Rapid Onset and an Absence of Diabetes-Related Antibodies | NEJM
Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study
Diabetes Typ 1: Inselautoantikörper als diagnostische Marker
Stiff Person Syndrome and Type 1 Diabetes Mellitus: a Case of the Chicken or the Egg? | SpringerLink
